Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Guide to Vanguard LifeStrategy Growth Investor Fund (VASGX)

Vanguard LifeStrategy Growth Investor (VASGX) a Zacks Ranked #2 (Buy) was incepted in September 1994 and is managed by Vanguard. The objective of this domestic hybrid fund is to seek long-term capital growth by investing in four Vanguard funds- Total Stock Market Index, Total International Stock Index, Total Bond Market Index, and Asset Allocation -that collectively have a target allocation of 80% stocks and technology. VASGX offers dividends semi-annually in June and December and capital gains if any, are distributed annually in December.

This Allocation Balanced product, as of the last filing, allocates their fund in seven major groups; Large Value, Foreign Stock, Intermediate Bond, Large Growth, Foreign Bond, Emerging Market and Small Growth.

Vanguard LifeStrategy Growth Investor, managed by Vanguard Group, carries an expense ratio of 0.17%. Moreover, VASGX requires a minimal initial investment of $3,000.

VASGX has a history of positive total returns for over 10 years. Specifically, the fund’s returns over the 3, 5 year benchmarks; 3 year 6.42% and 5 year 6.31%. To see how this fund performed compared in its category, please click here.

VASGX’s performance, as of the last filing, when compared to funds in its category was in the top 41% in 1 year, top 9% over the past 3 years, and in the 12% over the past 5 years.

Zacks Premium

To see the Zacks Mutual Fund Rank for the funds you’re interested in —plus, gain access to the Zacks Rank for your stocks and ETFs; Premium Screens; Equity Research Reports; Focus List portfolio of 50-longer-term stocks and more— start your 30-day free trial to Zacks Premium.


View All Zacks #1 Ranked Mutual Funds
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Get Your Free (VASGX): Fund Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research